Rankings
▼
Calendar
CAI Q3 2015 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
CAI
Caris Life Sciences, Inc.
$5B
Q3 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$66M
+11.7% YoY
Gross Profit
$39M
58.4% margin
Operating Income
$23M
35.1% margin
Net Income
$13M
19.6% margin
EPS (Diluted)
$0.62
QoQ Revenue Growth
+11.4%
Cash Flow
Operating Cash Flow
$41M
Free Cash Flow
-$27M
Stock-Based Comp.
$467,000
Balance Sheet
Total Assets
$2.0B
Total Liabilities
$1.5B
Stockholders' Equity
$475M
Cash & Equivalents
$64M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$66M
$59M
+11.7%
Gross Profit
$39M
$39M
-1.7%
Operating Income
$23M
$26M
-10.9%
Net Income
$13M
$16M
-20.8%
← FY 2015
All Quarters
Q4 2015 →